NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) Dante Genomics, a global leader in genomics and precision medicine, is pleased to announce that the Company’s.
Investegate announcements from Dante Genomics, Dante Genomics Unveils Digital Health Population Genomic Programs at the United Nations General Assembly Science Summit
NEW YORK, Oct. 04, 2022, a global leader in genomics and precision medicine, is pleased to announce that the Company's co-founder and CEO Andrea Riposati presented as an opening speaker on Tuesday, September
Dante Genomics, a global leader in genomics and precision medicine, today announced its partnership with TMA Precision Health, a company on a mission to improve the lives of rare disease patients everywhere, offering clinical whole genome sequencing to rare disease patients as the first step in diagnosing and .